Daniel J Renouf

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 8

Top Topics

Metastatic Colorectal Cancer

Prognostic Factors

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

Nature communications

NPJ precision oncology

Canadian journal of gastroenterology & hepatology

This page only lists publications with an associated author ORCID identifier.

Publications

Jonathan M Loree, Emma Titmuss, James T Topham, Hagen F Kennecke, Harriet E Feilotter, Shakeel Virk, Young S Lee, Kimberly C Banks, Katie Quinn, Aly Karsan, Daniel J Renouf, Derek J Jonker, Dongsheng Tu, Chris J O'Callaghan, Eric X Chen
Plasma versus Tissue Tumor Mutational Burden as Biomarkers of Durvalumab plus Tremelimumab Response in Patients with Metastatic Colorectal Cancer in the CO.26 Trial. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (15) (2024)
Jonathan M Loree, Emma Titmuss, James T Topham, Hagen F Kennecke, Harriet E Feilotter, Shakeel Virk, Young S Lee, Kimberly C Banks, Katie Quinn, Aly Karsan, Daniel J Renouf, Derek J Jonker, Dongsheng Tu, Chris J O'Callaghan, Eric X Chen
Plasma versus Tissue Tumor Mutational Burden as Biomarkers of Durvalumab plus Tremelimumab Response in Patients with Metastatic Colorectal Cancer in the CO.26 Trial. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (15) (2024)
Jonathan M Loree, Emma Titmuss, James T Topham, Hagen F Kennecke, Harriet E Feilotter, Shakeel Virk, Young S Lee, Kimberly C Banks, Katie Quinn, Aly Karsan, Daniel J Renouf, Derek J Jonker, Dongsheng Tu, Chris J O'Callaghan, Eric X Chen
Plasma versus tissue tumor mutational burden as biomarkers of durvalumab plus tremelimumab response in patients with metastatic colorectal cancer in the CO.26 trial. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Jonathan M Loree, Emma Titmuss, James T Topham, Hagen F Kennecke, Harriet E Feilotter, Shakeel Virk, Young S Lee, Kimberly C Banks, Katie Quinn, Aly Karsan, Daniel J Renouf, Derek J Jonker, Dongsheng Tu, Chris J O'Callaghan, Eric X Chen
Plasma versus Tissue Tumor Mutational Burden as Biomarkers of Durvalumab plus Tremelimumab Response in Patients with Metastatic Colorectal Cancer in the CO.26 Trial. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (15) (2024)
Erica S Tsang, Veronika Csizmok, Laura M Williamson, Erin Pleasance, James T Topham, Joanna M Karasinska, Emma Titmuss, Kasmintan A Schrader, Stephen Yip, Basile Tessier-Cloutier, Karen Mungall, Tony Ng, Sophie Sun, Howard J Lim, Jonathan M Loree, Janessa Laskin, Marco A Marra, Steven J M Jones, David F Schaeffer, Daniel J Renouf
Homologous recombination deficiency signatures in gastrointestinal and thoracic cancers correlate with platinum therapy duration. NPJ precision oncology 7 (1) (2023)
James T Topham, Erica S Tsang, Joanna M Karasinska, Andrew Metcalfe, Hassan Ali, Steve E Kalloger, Veronika Csizmok, Laura M Williamson, Emma Titmuss, Karina Nielsen, Gian Luca Negri, Sandra Elizabeth Spencer, Gun Ho Jang, Robert E Denroche, Hui-Li Wong, Grainne M O'Kane, Richard A Moore, Andrew J Mungall, Jonathan M Loree, Faiyaz Notta, Julie M Wilson, Oliver F Bathe, Patricia A Tang, Rachel Goodwin, Gregg B Morin, Jennifer J Knox, Steven Gallinger, Janessa Laskin, Marco A Marra, Steven J M Jones, David F Schaeffer, Daniel J Renouf
Integrative analysis of KRAS wildtype metastatic pancreatic ductal adenocarcinoma reveals mutation and expression-based similarities to cholangiocarcinoma. Nature communications 13 (1) (2022)
Daniel J Renouf, Jonathan M Loree, Jennifer J Knox, James T Topham, Petr Kavan, Derek Jonker, Stephen Welch, Felix Couture, Frederic Lemay, Mustapha Tehfe, Mohammed Harb, Nathalie Aucoin, Yoo-Joung Ko, Patricia A Tang, Ravi Ramjeesingh, Brandon M Meyers, Christina A Kim, Pan Du, Shidong Jia, David F Schaeffer, Sharlene Gill, Dongsheng Tu, Chris J O'Callaghan
The CCTG PA.7 phase II trial of gemcitabine and nab-paclitaxel with or without durvalumab and tremelimumab as initial therapy in metastatic pancreatic ductal adenocarcinoma. Nature communications 13 (1) (2022)
Erica S Tsang, Jonathan M Loree, Janine M Davies, Sharlene Gill, David Liu, Stephen Ho, Daniel J Renouf, Howard J Lim, Hagen F Kennecke
Efficacy and Prognostic Factors for Y-90 Radioembolization (Y-90) in Metastatic Neuroendocrine Tumors with Liver Metastases. Canadian journal of gastroenterology & hepatology 2020 (2020)